Atlas Trials

the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis

Clinical trial NCT06856031 · COMPLETED

Trial details

NCT number
NCT06856031
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
IBD (Inflammatory Bowel Disease)
Start date
2020-11-01
Primary completion
2024-11-30
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.